During the past decade, University of Ottawa Eye Institute conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 8 clinical trials were completed, i.e. on average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Ottawa Eye Institute" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Apellis Pharmaceuticals, Inc." with 2 trials sponsored, "Lux Biosciences, Inc." with 2 trials sponsored, "Shire" with 2 trials sponsored and "Abbott Medical Optics" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Ottawa Eye Institute" #1 collaborator was "Canadian Glaucoma Clinical Research Council" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "University of Ottawa Eye Institute" are "Geographic Atrophy" (4 trials), "Macular Degeneration" (3 trials), "Panuveitis" (2 trials), "Uveitis, Intermediate" (2 trials) and "Uveitis, Posterior" (2 trials). Many other conditions were trialed in "University of Ottawa Eye Institute" in a lesser frequency.

Most popular intervention types in "University of Ottawa Eye Institute" are "Drug" (16 trials), "Other" (5 trials), "Procedure" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Sham Procedure" (4 trials), "Aflibercept" (3 trials), "Faricimab" (2 trials) and "LX211" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Ottawa Eye Institute" are 19 trials for "All" genders.

Currently, there are NaN active trials in "University of Ottawa Eye Institute". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in University of Ottawa Eye Institute, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Ottawa Eye Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".